These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 7539507)
41. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Patterson BK; Till M; Otto P; Goolsby C; Furtado MR; McBride LJ; Wolinsky SM Science; 1993 May; 260(5110):976-9. PubMed ID: 8493534 [TBL] [Abstract][Full Text] [Related]
42. Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line. Harouse JM; Collman RG; González-Scarano F J Virol; 1995 Dec; 69(12):7383-90. PubMed ID: 7494242 [TBL] [Abstract][Full Text] [Related]
43. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. Mondor I; Ugolini S; Sattentau QJ J Virol; 1998 May; 72(5):3623-34. PubMed ID: 9557643 [TBL] [Abstract][Full Text] [Related]
44. Detection of viral RNA in CD4(-)CD8(-) and CD4(-)CD8(+) lymphocytes in vivo in rhesus monkeys infected with simian immunodeficiency virus of macaques. Huete JM; Chatis PA; Schmitz JE; Kuroda MJ; Letvin NL; Reimann KA AIDS Res Hum Retroviruses; 2001 Mar; 17(4):349-60. PubMed ID: 11242521 [TBL] [Abstract][Full Text] [Related]
45. Detection of HIV-1 DNA in different subsets of human peripheral blood mononuclear cells using the polymerase chain reaction. Rapid communication. Hufert FT; von Laer D; Schramm C; Tárnok A; Schmitz H Arch Virol; 1989; 106(3-4):341-5. PubMed ID: 2570562 [TBL] [Abstract][Full Text] [Related]
46. Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies. Burkly L; Mulrey N; Blumenthal R; Dimitrov DS J Virol; 1995 Jul; 69(7):4267-73. PubMed ID: 7769687 [TBL] [Abstract][Full Text] [Related]
47. CD4 masking during human immunodeficiency virus type 1 infection, quantified on peripheral blood lymphocytes, is a potential marker of disease progression. Carrière D; Vendrell J; Berthier A; Atoui N; Salhi SL; Reynes J; Gros P; Fontaine C; Jansen A; Huguet M; Ait-Cheik L; Pau B J Infect Dis; 1996 Mar; 173(3):565-73. PubMed ID: 8627018 [TBL] [Abstract][Full Text] [Related]
48. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527 [TBL] [Abstract][Full Text] [Related]
49. Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. Cimarelli A; Zambruno G; Marconi A; Girolomoni G; Bertazzoni U; Giannetti A J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):230-5. PubMed ID: 8106964 [TBL] [Abstract][Full Text] [Related]
50. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Descours B; Petitjean G; López-Zaragoza JL; Bruel T; Raffel R; Psomas C; Reynes J; Lacabaratz C; Levy Y; Schwartz O; Lelievre JD; Benkirane M Nature; 2017 Mar; 543(7646):564-567. PubMed ID: 28297712 [TBL] [Abstract][Full Text] [Related]
51. PNA-in situ hybridization method for detection of HIV-1 DNA in virus-infected cells and subsequent detection of cellular and viral proteins. Hagiwara T; Hattori J; Kaneda T Methods Mol Biol; 2006; 326():139-49. PubMed ID: 16780198 [TBL] [Abstract][Full Text] [Related]
52. Cell type-specific heterogeneity of the HIV-1 V3 loop in infected individuals: selection of virus in macrophages and plasma. Yamashita A; Yamamoto N; Matsuda J; Koyanagi Y Virology; 1994 Oct; 204(1):170-9. PubMed ID: 7916512 [TBL] [Abstract][Full Text] [Related]
53. HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. Innocenti P; Ottmann M; Morand P; Leclercq P; Seigneurin JM AIDS Res Hum Retroviruses; 1992 Feb; 8(2):261-8. PubMed ID: 1347227 [TBL] [Abstract][Full Text] [Related]
54. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. Bagnarelli P; Menzo S; Valenza A; Manzin A; Giacca M; Ancarani F; Scalise G; Varaldo PE; Clementi M J Virol; 1992 Dec; 66(12):7328-35. PubMed ID: 1433521 [TBL] [Abstract][Full Text] [Related]
55. Human Kupffer cells infected with HIV-1 in vivo. Hufert FT; Schmitz J; Schreiber M; Schmitz H; Rácz P; von Laer DD J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):772-7. PubMed ID: 8099611 [TBL] [Abstract][Full Text] [Related]
56. gp120-Independent infection of CD4(-) epithelial cells and CD4(+) T-cells by HIV-1. Chow YH; Yu D; Zhang JY; Xie Y; Wei OL; Chiu C; Foroohar M; Yang OO; Park NH; Chen IS; Pang S J Acquir Immune Defic Syndr; 2002 May; 30(1):1-8. PubMed ID: 12048357 [TBL] [Abstract][Full Text] [Related]
57. Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection. Butera ST; Perez VL; Wu BY; Nabel GJ; Folks TM J Virol; 1991 Sep; 65(9):4645-53. PubMed ID: 1678437 [TBL] [Abstract][Full Text] [Related]
58. Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities. Schmid P; Conrad A; Syndulko K; Singer EJ; Handley D; Li X; Tao G; Fahy-Chandon B; Tourtellotte WW J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):777-88. PubMed ID: 7912728 [TBL] [Abstract][Full Text] [Related]
59. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161 [TBL] [Abstract][Full Text] [Related]
60. Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26. Lazaro I; Naniche D; Signoret N; Bernard AM; Marguet D; Klatzmann D; Dragic T; Alizon M; Sattentau Q J Virol; 1994 Oct; 68(10):6535-46. PubMed ID: 7916060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]